TSS
TLSI icon

Two Sigma Securities’s TriSalus Life Sciences TLSI Stock Holding History

Two Sigma Securities’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,596
Closed -$58.5K – 2076
2025
Q1 		$58.5K Buy
+10,596
New +$56.4K 0.01% 993
2024
Q4 		– Sell
-10,192
Closed -$47K – 3151
2024
Q3 		$47K Buy
+10,192
New +$54K ﹤0.01% 2386

Other funds holding TLSI

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Securities's TLSI Position: Q2 2025 in Review

Two Sigma Securities sold out of TriSalus Life Sciences (TLSI) in Q2 2025, closing a stake of 10,596 shares — an estimated $58.5K sold.

Two Sigma Securities first reported a position in TLSI in Q3 2024 and held it in 2 quarters. The position peaked at $58.5K in Q1 2025. 48 funds tracked by Wall St. Rank hold TLSI as of Q2 2025.

  • Two Sigma Securities reported no remaining TriSalus Life Sciences position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Securities sold 10,596 TriSalus Life Sciences shares in Q2 2025, an estimated $58.5K.
  • Two Sigma Securities first reported a position in TriSalus Life Sciences in Q3 2024 and held it in 2 quarters.
  • Two Sigma Securities's TriSalus Life Sciences position peaked at $58.5K in Q1 2025.
  • 48 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.